Association of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosis
Open Access
- 13 February 2025
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 65 (6) , 2400276
Abstract
Background: There is a pressing need to identify early biomarkers of lung involvement in systemic sclerosis to start antifibrotic therapy as soon as possible. We aimed to identify extracellular vesicle-derived microRNAs (miRNAs) that are differentially expressed between systemic sclerosis patients with and without interstitial lung disease, and to explore their diagnostic value and functional properties.Methods: Small extracellular vesicles derived from plasma were isolated from 91 well-characterised patients with systemic sclerosis with (n=45) and without (n=46) interstitial lung disease and 43 matched healthy subjects. Small RNA-sequencing followed by quantitative reverse transcriptase PCR were used to identify and validate small extracellular vesicle miRNAs associated with systemic sclerosis-associated interstitial lung disease. Correlations between systemic sclerosis-associated interstitial lung disease miRNAs and clinical parameters were assessed, as well as the effect of related miRNAs/small extracellular vesicles on fibrosis.Results: We identified a four-miRNA signature associated with interstitial lung disease in the context of systemic sclerosis (miR-584-5p, miR-744-5p, miR-1307-3p and miR-10b-5p) (area under the receiver operating characteristic curve 0.85, 95% CI 0.76–0.94; p<0.0001). Deeper analysis revealed a correlation of these candidates with pulmonary function tests (diffusing capacity of the lung for carbon monoxide and forced vital capacity), highlighting their use in monitoring lung fibrosis progression in systemic sclerosis patients. Furthermore, small extracellular vesicle miRNAs associated with systemic sclerosis-associated interstitial lung disease are positively correlated with and enriched in circulating lymphocytes, suggesting that these immune cells are their cellular source. Finally, functional studies highlighted altered functional properties of small extracellular vesicles in the context of systemic sclerosis-associated interstitial lung disease, mainly due to the transfer of profibrotic miR-584-5p in lung fibroblasts.Conclusions: Our small extracellular vesicle-based biomarker approach identified a promising four‑miRNA signature characteristic of interstitial lung disease in systemic sclerosis patients. Furthermore, the profibrotic properties of small extracellular vesicles associated with systemic sclerosis-associated interstitial lung disease suggest a prominent role of these vesicles in systemic sclerosis severity.Keywords
Funding Information
- CHU de Liège/Université de Liège (Fonds Léon Fredericq)
- CHU de Liège (Fonds d’Investissement de Recherche Scientifique)
This publication has 58 references indexed in Scilit:
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2013
- The miR-146a rs2910164 C/G polymorphism is associated with telangiectasia in systemic sclerosisClinical and Experimental Dermatology, 2012
- Altered microRNA expression profile with miR-146a upregulation in CD4+T cells from patients with rheumatoid arthritisArthritis Research & Therapy, 2010
- Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotypeLaboratory Investigation, 2010
- The impact of microRNAs on protein outputNature, 2008
- Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritisArthritis & Rheumatism, 2008
- Scleroderma: from cell and molecular mechanisms to disease modelsTrends in Immunology, 2005
- Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosisMolecular Immunology, 2004
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004
- Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivityNature Immunology, 2001